ReviewMedical oncology (Northwood, London, England)2025

The landscape of cyclin-dependent kinase 4/6 inhibitors in solid malignancies: emphasis on immunotherapy combinatorial strategies.

Sara A Hussein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.